Zealand Pharma A/S ADR (ZEAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 185,188 | 126,625 | 146,557 | 136,325 | 230,664 |
| Marketable Securities | 44,755 | 45,375 | 45,718 | 47,300 | N/A |
| Receivables | 2,132 | 1,443 | 1,058 | 1,241 | 1,227 |
| TOTAL | $234,977 | $177,196 | $196,925 | $186,726 | $233,260 |
| Non-Current Assets | |||||
| PPE Net | 2,949 | 2,077 | 2,241 | 2,476 | 2,401 |
| Investments And Advances | 5,117 | 4,948 | 5,054 | 5,161 | 1,507 |
| Other Non-Current Assets | 12,282 | 927 | 1,329 | 438 | 431 |
| TOTAL | $20,349 | $7,952 | $8,624 | $8,074 | $4,340 |
| Total Assets | $255,326 | $185,148 | $205,549 | $194,800 | $237,599 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,482 | 6,717 | 4,470 | 5,134 | 3,824 |
| Other current liabilities | 8,201 | 8,378 | 8,157 | 11,769 | 31,824 |
| TOTAL | $45,356 | $39,551 | $40,520 | $16,903 | $44,039 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 22,467 | 23,953 | 26,987 | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $45,356 | $39,551 | $40,520 | $16,903 | $44,039 |
| Shareholders' Equity | |||||
| Common Shares | 5,344 | 4,791 | 4,819 | 4,877 | 4,798 |
| Retained earnings | -186,228 | -171,175 | -152,123 | -148,993 | -120,280 |
| TOTAL | $209,970 | $145,597 | $165,029 | $168,999 | $193,560 |
| Total Liabilities And Equity | $255,326 | $185,148 | $205,549 | $185,902 | $237,599 |